84 research outputs found
Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases
Deposition of immunoglobulin light chains is a result of clonal proliferation of monoclonal plasma cells that secrete free immunoglobulin light chains, also called Bence Jones proteins (Bence Jones proteins). These Bence Jones proteins are present in circulation in large amounts and excreted in urine in various light chain diseases such as light chain amyloidosis (AL), light chain deposition disease (LCDD) and multiple myeloma (MM). BJP from patients with AL, LCDD and MM were purified from their urine and studies were performed to determine their secondary structure, thermodynamic stability and aggregate formation kinetics. Our results show that LCDD and MM proteins have the lowest free energy of folding while all proteins show similar melting temperatures. Incubation of the BJP at their melting temperature produced morphologically different aggregates: amyloid fibrils from the AL proteins, amorphous aggregates from the LCDD proteins and large spherical species from the MM proteins. The aggregates formed under in vitro conditions suggested that the various proteins derived from patients with different light chain diseases might follow different aggregation pathways
Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
Renal involvement is a frequent consequence of plasma cell dyscrasias. The most common entities are light chain amyloidosis, monoclonal immunoglobulin deposition disease and myeloma cast nephropathy. Despite a common origin, each condition has its own unique histologic and pathophysiologic characteristic which requires a renal biopsy to distinguish. Recent studies have shown urinary exosomes containing kidney-derived membrane and cytosolic proteins that can be used to probe the proteomics of the entire urinary system from the glomerulus to the bladder. In this study, we analyzed urine exosomes to determine the differences between exosomes from patients with light chain amyloidosis, multiple myeloma, monoclonal gammopathy of undetermined significance, and non-paraproteinemia related kidney disease controls. In patients with light chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance, immunoreactive proteins corresponding to monomeric light chains were found in exosomes by western blot. In all of the amyloidosis samples with active disease, high molecular weight immunoreactive species corresponding to a decamer were found which were not found in exosomes from the other diseases or in amyloidosis exosomes from patients in remission. Few or no light chains monomeric bands were found in non-paraproteinemia related kidney disease controls. Our results showed that urinary exosomes may have tremendous potential in furthering our understanding of the pathophysiology and diagnosis of plasma cell dyscrasia related kidney diseases
Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity
Light
chain amyloidosis is a protein misfolding disease in which
immunoglobulin light chains aggregate as insoluble fibrils that accumulate
in extracellular deposits. Amyloid fibril formation <i>in vitro</i> has been described as a nucleation–polymerization, autocatalytic
reaction in which nascent fibrils catalyze formation of new fibrils,
recruiting soluble protein into the fibril. In this context, it is
also established that preformed fibrils or “seeds” accelerate
fibril formation. In some cases, seeds with a substantially different
sequence are able to accelerate the reaction, albeit with a lower
efficiency. In this work, we studied the recruitment and addition
of monomers in the presence of seeds of five immunoglobulin light
chain proteins, covering a broad range of protein stabilities and
amyloidogenic properties. Our data reveal that in the presence of
homologous or heterologous seeds, the fibril formation reactions become
less stochastic than <i>de novo</i> reactions. The kinetics
of the most amyloidogenic proteins (AL-T05 and AL-09) do not present
significant changes in the presence of seeds. Amyloidogenic protein
AL-103 presented fairly consistent acceleration with all seeds. In
contrast, the less amyloidogenic proteins (AL-12 and κI) presented
dramatic differential effects that are dependent on the kind of seed
used. κI had a poor efficiency to elongate preformed fibrils.
Together, these results indicate that fibril formation is kinetically
determined by the conformation of the amyloidogenic precursor and
modulated by the differential ability of each protein to either nucleate
or elongate fibrils. We observe morphological and conformational properties
of some seeds that do not favor elongation with some proteins, resulting
in a delay in the reaction
Thermal Stability Threshold for Amyloid Formation in Light Chain Amyloidosis
Light chain (AL) amyloidosis is a devastating disease characterized by amyloid deposits formed by immunoglobulin light chains. Current available treatments involve conventional chemotherapy and autologous stem cell transplant. We have recently concluded a phase III trial comparing these two treatments. AL amyloidosis patients who achieve hematological complete response (CR) do not necessarily achieve organ response regardless of the treatment they received. In order to investigate the possible correlation between amyloid formation kinetics and organ response, we selected AL amyloidosis patients from the trial with kidney involvement and CR after treatment. Six patients were selected and their monoclonal immunoglobulin light chains were characterized. The proteins showed differences in their stability and their kinetics of amyloid formation. A correlation was detected at pH 7.4, showing that less stable proteins are more likely to form amyloid fibrils. AL-T03 is too unstable to form amyloid fibrils at pH 7.4. This protein was found in the only patient in the study that had organ response, suggesting that partially folded species are required for amyloid formation to occur in AL amyloidosis
- …